IBRX
NantKwest Inc is a biotechnology firm operating mainly in the United States. It undertakes research and discovery of drugs to cure virally-induced cancers, bacterial and fungal diseases. Its pipeline product includes taNK, haNK, and aNK.
Quantitative Factor Evaluation • Updated 2026-09-17
Subscribe to unlock
Subscribe to unlock
Subscribe to unlock
Subscribe to unlock
Subscribe to unlock
Subscribe to Prism Premium to see every stock, unlock full factor-grade breakdowns, and get B-/A rated picks.
Subscribe to Prism Premium